SCHEMBL8058097

SCHEMBL8058097

COc1ccc(-c2ccccc2S(=O)(=O)Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.51
ABCB1 P08183 1/20 0.51
BCR P11274 1/20 0.51
HDAC4 P56524 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
PTPN1 P18031 1/20 0.49
IDO1 P14902 1/20 0.48
MAPT P10636 5/20 0.47
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 2/20 0.47
TP53 P04637 1/20 0.47
TSHR P16473 1/20 0.47
PTGS2 P35354 2/20 0.47
STAT3 P40763 1/20 0.46
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28447440 0.86 ABL1 (0.55) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL27550657 0.84 PTGS2 (0.55) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL4662973 0.83 SCN9A (0.58) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL31331765 0.83 SCN9A (0.58) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL8819737 0.83 SMN1; SMN2 (0.46) ABL1ABCB1BCRSMN1; SMN2PTGS2
SCHEMBL5682823 0.80 CA12 (0.42) MAPTRAB9ANPC1TP53TSHR
SCHEMBL6291041 0.80 PTPN1 (0.50) PTPN1MAPTRAB9ASMN1; SMN2NPC1
SCHEMBL313390 0.79 ALDH1A1 (0.46) HDAC4HDAC2HDAC8PTGS2ALDH1A1
SCHEMBL14572634 0.79 SCN9A (0.47) PTGS2PTGS1SCN9A
SCHEMBL4202592 0.78 PTGS2 (0.55) MAPTRAB9APTGS2HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083951-A FOR THE TREATMENT OF DISEASES OR MEDICAL CONDITIONS SUCH AS HYPERTENSION, PULMONARY HYPERTENSION, CARDIAC OR CEREBRAL CIRCULATORY DISEASE AND RENAL DISEASE ZENECA LIMITED (GB) 2000-07-04 US disclosed
EP-0752986-B1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LTD (GB) 1999-05-19 EP disclosed
US-5861401-A TREATMENT OF CONGESTIVE HEART FAILURE ZENECA LIMITED (GB) 1999-01-19 US disclosed
EP-0752986-A1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1997-01-15 EP disclosed
WO-1995026957-A1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1995-10-12 WO disclosed